BMY (bristol myers squibb) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMY (bristol myers squibb)

BMY 42.83

-1.3%

Oct 28 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zax who wrote (184)	6/24/2019 7:01:06 PM
From: Miljenko Zuanic	Read Replies (1) of 194

<Remicade-type blockbuster> It is not revlimid type blockbuster, unless they bump WS prive by 20X, as they did with revlimid. But, projected $3B in sale is achievable. With current 1.8B/Y and 5X (to be generous) it may be worth $9B. That is not bad. Still, how are things going for BMY, one more main failure with Opdivo (and that is not impossible), stock is going down to ~40. And CELG bag-holder will be very unhappy with it. PS: I sold my BMY share the day they announce voting results. Or day before, whatever.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next